Picture of Celyad Oncology SA logo

CYAD — Celyad Oncology SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Celyad ‍​Q1 Treasury Position At 33.8 Million Euros

May 7 (Reuters) - CELYAD SA  CYAD.BR :
    * Q1 TREASURY POSITION OF EUR 33.8 MILLION
    * CONFIRMS ITS PREVIOUS GUIDANCE THAT TREASURY POSITION
SHOULD BE
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURE
REQUIREMENTS THROUGH H1 2021
    * ‍​Q1 NET CASH BURN EUR 5.5 MILLION
    * WE ANTICIPATE ANNOUNCING ADDITIONAL DATA FROM OUR CYAD-101
ALLOSHRINK PHASE 1 TRIAL AT AMERICAN SOCIETY OF CLINICAL
ONCOLOGY - CEO
    * WE ANTICIPATE FILING IND APPLICATION FOR OUR LEAD
SHRNA-BASED
ALLOGENEIC CANDIDATE CYAD-211 OVER NEXT FEW MONTHS - CEO
    * WE ANTICIPATE PROVIDING CLINICAL UPDATE ON OUR
RELAPSED/REFRACTORY AML AND MDS PROGRAM IN H2 2020 - CEO

Source text for Eikon:  ID:nGNX11qX9X 
Further company coverage:  CYAD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Celyad Oncology SA

See all news